|
1
|
Sun X, Duan X, Wang C, Liu Z, Sun P, Huo
X, Ma X, Sun H, Liu K and Meng Q: Protective effects of
glycyrrhizic acid against non-alcoholic fatty liver disease in
mice. Eur J Pharmacol. 806:75–82. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yahagi M, Tsuruta M, Hasegawa H,
Okabayashi K and Kitagawa Y: Non-alcoholic fatty liver disease
fibrosis score predicts hematological toxicity of chemotherapy
including irinotecan for colorectal cancer. Mol Clin Oncol.
6:529–533. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chan WK, Nik Mustapha NR, Wong GL, Wong VW
and Mahadeva S: Controlled attenuation parameter using the
FibroScan® XL probe for quantification of hepatic
steatosis for non-alcoholic fatty liver disease in an Asian
population. United European Gastroenterol J. 5:76–85. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morimoto T, Mineharu Y, Ono K and
Nakatochi M: Significant association of RNF213 p.R4810K, a moyamoya
susceptibility variant, with coronary artery disease. PLoS One.
12:e01756492017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Silveira de Souza VV, Soares Torres F,
Hochhegger B, Watte G, Sartori G, Lucchese F and Azambuja Gonçalves
B: Performance of ultra-low-dose CT for the evaluation of coronary
calcification: A direct comparison with coronary calcium score.
Clin Radiol. 72:745–750. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Raman SV and Zareba KM: Coronary artery
disease testing: Past, present, and future. JACC Cardiovasc
Imaging. 16:285–297. 2017.
|
|
7
|
Verna EC: Non-alcoholic fatty liver
disease and non-alcoholic steatohepatitis in patients with HIV.
Lancet Gastroenterol Hepatol. 2:211–223. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Degasperi E and Colombo M: Distinctive
features of hepatocellular carcinoma in non-alcoholic fatty liver
disease. Lancet Gastroenterol Hepatol. 2:156–164. 2017.PubMed/NCBI
|
|
9
|
Maurice JB, Patel A, Scott AJ, Patel K,
Thursz M and Lemoine M: Prevalence and risk factors of
non-alcoholic fatty liver disease in HIV-monoinfection: A
systematic review and meta-analysis. AIDS. 12:487–491. 2017.
|
|
10
|
Sandri A, Petersen RH, Decaluwé H, Moons
J, Ferguson MK, Hansen HJ and Brunelli A: Coronary artery disease
is associated with an increased mortality rate following
video-assisted thoracoscopic lobectomy. J Thorac Cardiovasc Surg.
154:352–357. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schmidt B, Frölich S, Dragano N, Frank M,
Eisele L, Pechlivanis S, Forstner AJ, Nöthen MM, Mahabadi AA, Erbel
R, et al: Socioeconomic status interacts with the genetic effect of
a chromosome 9p21.3 common variant to influence coronary artery
calcification and incident coronary events in the Heinz Nixdorf
Recall study (risk factors, evaluation of coronary calcium, and
lifestyle). Circ Cardiovasc Genet. 10:e0014412017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ebell MH: PCI has more benefits and harms
than CABG for selected patients with left main coronary artery
disease. Am Fam Physician. 95:455–456. 2017.PubMed/NCBI
|
|
13
|
Kodama R, Muraki S, Iidaka T, Oka H,
Teraguchi M, Kagotani R, Asai Y, Hashizume H, Yoshida M, Kawaguchi
H, et al: Serum levels of matrix metalloproteinase-3 and
autoantibodies related to rheumatoid arthritis in the general
Japanese population and their association with osteoporosis and
osteoarthritis: The ROAD study. J Bone Miner Metab. 6:435–447.
2017.
|
|
14
|
Gudbrandsdottir S, Ghanima W, Nielsen CH,
Feng X, Hasselbalch HC and Bussel J: Effect of
thrombopoietin-receptor agonists on circulating cytokine and
chemokine levels in patients with primary immune thrombocytopenia
(ITP). Platelets. 28:478–483. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoo HJ, Hwang SY, Choi JH, Lee HJ, Chung
HS, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, et al: Association of
leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic
syndrome, and atherosclerosis. PLoS One. 12:e01747172017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Napoleão P, Potapova E and Moleirinho S:
Soluble CD40 ligand profiles in patients with septic shock. Clin
Hemorheol Microcirc. 9:25–32. 2014.
|
|
17
|
Ma S, Chen X, Wang L and Wei Y: Repairing
effects of ICAM-1-expressing mesenchymal stem cells in mice with
autoimmune thyroiditis. Exp Ther Med. 7:25–32. 2012.
|
|
18
|
Abo-Hagar HH, Abo-Elezz AA, Mehrez M,
Mabrouk MM and Elshora OA: Diagnostic efficacy of serum amyloid A
protein and soluble intercellular adhesion molecule 1 in pediatric
ventilator-associated pneumonia. J Intensive Care Med.
83:8850666177025982017. View Article : Google Scholar
|
|
19
|
Walker DG, Lue LF, Tang TM and Adler CH:
Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1)
levels in brains of Lewy body disorder cases are associated with
amounts of Alzheimer's pathology not α-synuclein pathology.
Neurobiol Aging. 15:97–110. 2013.
|
|
20
|
Mahmoodi K, Kamali K and Karami E: Plasma
concentration, genetic variation, and gene expression levels of
matrix metalloproteinase 9 in Iranian patients with coronary artery
disease. J Res Med Sci. 4:328–335. 2010.
|
